Liu, Zhaoyun
Yu, Bo
Su, Mu
Yuan, Chenxi
Liu, Cuicui
Wang, Xinzhao
Song, Xiang
Li, Chao
Wang, Fukai
Ma, Jianli
Wu, Meng
Chen, Dawei
Yu, Jinming
Yu, Zhiyong http://orcid.org/0000-0002-2569-9458
Funding for this research was provided by:
the Academic Promotion Program of Shandong First Medical University (2019ZL002)
Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences (2019RU071)
the foundation of National Natural Science Foundation of China (81627901, 81972863, 82030082)
the foundation of Natural Science Foundation of Shandong (ZR2023QH187)
the foundation of China Postdoctoral Science Foundation (2023M732024)
Article History
Received: 18 December 2022
Accepted: 8 November 2023
First Online: 12 December 2023
Declarations
:
: Approval for this prospective study was obtained from the Human Research Ethics Committee of Shandong Cancer Hospital (SDTHEC201802002) and was registered at clinicaltrial.gov (clinical trial No. NCT03688035). All patients provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.